OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Pim kinase inhibitors increase gilteritinib cytotoxicity in FLT3-ITD acute myeloid leukemia through GSK-3β activation and c-Myc and Mcl-1 proteasomal degradation
Jonelle K. Lee, Aditi Chatterjee, Mario Scarpa, et al.
Cancer Research Communications (2024) Vol. 4, Iss. 2, pp. 431-445
Open Access | Times Cited: 4
Jonelle K. Lee, Aditi Chatterjee, Mario Scarpa, et al.
Cancer Research Communications (2024) Vol. 4, Iss. 2, pp. 431-445
Open Access | Times Cited: 4
Showing 4 citing articles:
REDD1 is a determinant of the sensitivity of renal cell carcinoma cells to autophagy inhibition that can be therapeutically exploited by targeting PIM activity
Jennifer S. Carew, Claudia M. Espitia, S. Sureshkumar, et al.
Cancer Letters (2025) Vol. 613, pp. 217496-217496
Open Access
Jennifer S. Carew, Claudia M. Espitia, S. Sureshkumar, et al.
Cancer Letters (2025) Vol. 613, pp. 217496-217496
Open Access
Concurrent inhibition of FLT3 and sphingosine kinase-1 triggers synergistic cytotoxicity in midostaurin resistant FLT3-ITD positive acute myeloid leukemia cells via blocking FLT3/STAT5A signaling to induce apoptosis
Melisa Tecik, Aysun Adan
Journal of Chemotherapy (2025), pp. 1-17
Closed Access
Melisa Tecik, Aysun Adan
Journal of Chemotherapy (2025), pp. 1-17
Closed Access
Preclinical development of tuspetinib for the treatment of acute myeloid leukemia
Himangshu Sonowal, William G. Rice, Rafael Bejar, et al.
Cancer Research Communications (2024) Vol. 5, Iss. 1, pp. 74-83
Open Access | Times Cited: 1
Himangshu Sonowal, William G. Rice, Rafael Bejar, et al.
Cancer Research Communications (2024) Vol. 5, Iss. 1, pp. 74-83
Open Access | Times Cited: 1
REDD1 is a determinant of the sensitivity of renal cell carcinoma cells to autophagy inhibition that can be therapeutically exploited by targeting PIM kinase activity
Jennifer S. Carew, Claudia M. Espitia, S. Sureshkumar, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Jennifer S. Carew, Claudia M. Espitia, S. Sureshkumar, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
